A Study of RAY1225 in Participants With Impaired Liver Function

NCT06577415 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment

Interventions

DRUG: RAY1225

Sponsor

Guangdong Raynovent Biotech Co., Ltd